Turner Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Turner Investments’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-33,708	Closed	-$753K	–	311
2016 Q4	$753K	Hold	33,708	–	–	0.3%	121
2016 Q3	$626K	Sell	33,708 -13,340	-28%	-$252K	0.21%	135
2016 Q2	$767K	Sell	47,048 -50,730	-52%	-$746K	0.24%	116
2016 Q1	$1.14M	Buy	+97,778	New	+$1.09M	0.31%	104
2015 Q2	–	Sell	-79,980	Closed	-$708K	–	466
2015 Q1	$708K	Sell	79,980 -10,020	-11%	-$101K	0.13%	191
2014 Q4	$903K	Buy	+90,000	New	+$772K	0.11%	282
2013 Q4	–	Sell	-537,509	Closed	-$5.33M	–	697
2013 Q3	$5.33M	Sell	537,509 -88,141	-14%	-$694K	0.09%	262
2013 Q2	$3.69M	Buy	+625,650	New	+$2.11M	0.05%	367

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Turner Investments's BEAT Position: Q1 2017 in Review

Turner Investments sold out of BioTelemetry, Inc. (BEAT) in Q1 2017, closing a stake of 33,708 shares — an estimated $753K sold.

Turner Investments first reported a position in BEAT in Q2 2013 and held it in 8 quarters. The position peaked at $5.33M in Q3 2013. 178 funds tracked by Wall St. Rank hold BEAT as of Q1 2017.

Turner Investments reported no remaining BioTelemetry, Inc. position as of Q1 2017 after selling out during the quarter.
Turner Investments sold 33,708 BioTelemetry, Inc. shares in Q1 2017, an estimated $753K.
Turner Investments first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 8 quarters.
Turner Investments's BioTelemetry, Inc. position peaked at $5.33M in Q3 2013.
178 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.